SCHEMBL5353897

SCHEMBL5353897

CC(Cl)NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29028729 0.78
SCHEMBL4013459 0.78
SCHEMBL7195013 0.77
SCHEMBL4011389 0.75 LMNA (0.47)
SCHEMBL24463 0.75
SCHEMBL11226772 0.73
SCHEMBL27662 0.73
SCHEMBL1228638 0.73 NPC1 (0.40)
SCHEMBL1938866 0.73
SCHEMBL2448286 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720072-A2 RAS INHIBITORS Revolution Medicines, Inc. (US) 2026-04-08 EP claimed
US-20260078133-A1 RAS INHIBITORS Revolution Medicines, Inc. 2026-03-19 US claimed
EP-4688790-A1 MACROCYCLIC RAS INHIBITORS Revolution Medicines, Inc. (US) 2026-02-11 EP claimed
US-20260028353-A1 MACROCYCLIC RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT 2026-01-29 US claimed
CN-115873020-B RAS inhibitors 锐新医药公司 2025-06-13 CN claimed
US-12252497-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2025-03-18 US claimed
US-20250051306-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2025-02-13 US claimed
WO-2024249299-A2 RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-12-05 WO claimed
CN-118852330-A RAS inhibitors for the treatment of cancer 锐新医药公司 2024-10-29 CN claimed
WO-2024211712-A1 CONDENSED MACROCYCLIC COMPOUNDS AS RAS INHIBITORS Revolution Medicines, Inc. (US) 2024-10-10 WO claimed
WO-2017109067-A1 PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING UREA OR A DERIVATIVE THEREOF, A POLYOL AND AN AMINO SILICONE L'OREAL (FR) 2017-06-29 WO claimed
US-20160199276-A1 COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF L'OREAL (FR) 2016-07-14 US claimed
EP-2988830-A2 COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF L'Oréal (FR) 2016-03-02 EP claimed
US-20150305999-A1 COMPOSITION COMPRISING A DICARBONYL DERIVATIVE AND METHOD FOR STRAIGHTENING THE HAIR USING THIS COMPOSITION L'OREAL (FR) 2015-10-29 US claimed
EP-2916808-A1 COMPOSITION COMPRISING A DICARBONYL DERIVATIVE AND METHOD FOR STRAIGHTENING THE HAIR USING THIS COMPOSITION L'Oréal (FR) 2015-09-16 EP claimed
WO-2014174075-A2 COMPOSITION FOR STRAIGHTENING KERATIN FIBRES, COMPRISING A UREA AND/OR A UREA DERIVATIVE AND A NONIONIC, CATIONIC, AMPHOTERIC OR ANIONIC ASSOCIATIVE POLYMERIC THICKENER, PROCESS AND USE THEREOF L'OREAL (FR) 2014-10-30 WO claimed
WO-2014072658-A1 COMPOSITION COMPRISING A DICARBONYL DERIVATIVE AND METHOD FOR STRAIGHTENING THE HAIR USING THIS COMPOSITION L'OREAL (FR) 2014-05-15 WO claimed
CN-1094402-A Antineoplastic heteronaphthoquinones IAF BIOCHEM INT (CA) 1994-11-02 CN claimed
EP-0067019-B1 NOVEL NITROSOUREA COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Kimura, Goro (JP) 1986-03-19 EP claimed
EP-0067019-A1 Novel nitrosourea compound, method for preparing same, and pharmaceutical composition containing same Kimura, Goro (JP) 1982-12-15 EP claimed